CMS Tells MA Plans Not To Exclude Biogen’s Qalsody Because Of Accelerated Approval

 
• By Cathy Kelly
  
The letter was hailed as good news for Medicare coverage of rare disease treatments. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Medicare

More from Geography